Hisamitsu Pharmaceutical Co., Inc. (TSE:4530) announces a share repurchase program. Under the program, the company will repurchase 2,000,000 shares, representing 2.57% of its issued share capital, for ¥10,000 million. The purpose of the program is to improve capital efficiency and return profits to shareholders and to carry out a flexible capital policy.

The program will run until February 29, 2024. As of May 31, 2023, the company had 77,773,522 shares issued (excluding treasury stock) and 7,391,373 shares in treasury.